The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ASTERIAS BIOTHERAPEUTICS INC COM SER A 04624N107 7,674 5,292,156 SH   DFND 1 5,292,156 0 0
AXON ENTERPRISE INC COM 05464C101 29,878 760,062 SH   DFND 1 760,062 0 0
BIOTIME INC COM 09066L105 80,623 29,971,561 SH   DFND 1 29,971,561 0 0
DELTA AIR LINES INC DEL COM NEW 247361702 10,962 200,000 SH Put DFND 1 200,000 0 0
ISHARES TR RUSSELL 2000 ETF 464287655 63,769 420,000 SH   DFND 1 420,000 0 0
ONCOCYTE CORPORATION COM 68235C107 15,886 7,564,934 SH   DFND 1 7,564,934 0 0
MONSTER BEVERAGE CORP NEW COM 61174X109 273,104 4,773,708 SH   DFND 1 4,773,708 0 0
MONSTER BEVERAGE CORP NEW COM 61174X109 45,768 800,000 SH Put DFND 1 800,000 0 0
STAAR SURGICAL CO COM PAR $0.01 852312305 160,657 10,855,179 SH   DFND 1 10,855,179 0 0